Motley Fool
Teladoc Health (NYSE: TDOC), to many investors the top stock in the mushrooming telehealth segment, looked a bit sickly on Tuesday. The latest in a series of analyst price target cuts was the primary reason for the slide. Following similar adjustments from several of his peers in the stock forecasting realm, Canaccord Genuity analyst Richard Close has chopped his price target for Teladoc.
A woman shops for baby formula at Target in Annapolis, Maryland, on May 16, 2022, as a nationwide shortage of...
As companies flee Russia, their Russian employees are seeing their jobs suddenly vanish. Tens of thousands of such employees will...
Microsoft CEO Satya Nadella speaks during the Microsoft Annual Shareholders Meeting at the Meydenbauer Center on November 28, 2018 in...
In this article RIVN Production of electric Amazon delivery vans on April 11, 2022 at Rivian's plant in Normal, Ill....
In this photo illustration, Twitter account of Elon Musk is seen on a smartphone screen and Twitter logo in the...
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
